05:08 PM EDT, 10/21/2025 (MT Newswires) -- RAPT Therapeutics ( RAPT ) on late Tuesday proposed an underwritten public offering of its common stock.

The company plans to offer all shares itself and may grant underwriters a 30-day option to buy up to 15% more shares at the offering price, RAPT said.

RAPT added that the offering's completion, size, and terms will depend on market conditions.

Shares of the company were down 5.3% in recent after-hours activity.